{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:57:11Z","timestamp":1790776631179,"version":"4.1.0"},"reference-count":73,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Bladder cancer is the 10th most common cancer worldwide. Approximately 75% of patients with bladder cancer will present with non-muscle invasive disease. Patients are usually treated with transurethral resection of bladder tumor (TURBT), in addition to adjuvant intravesical therapy (chemotherapy or anti-cancer immunotherapy with Bacillus Calmette Guerin- BCG) for those at intermediate-risk and high-risk of recurrence and progression. For many years, urine has been thought to be \u201csterile\u201d; however, advanced microbiological and molecular techniques, including 16S ribosomal RNA (16S rRNA) sequencing, have negated that previous paradigm and confirmed the presence of a urinary microbiome. The urinary microbiome has been associated with several urological diseases, including interstitial cystitis, urgency urinary incontinence, neurogenic bladder dysfunction, and others. More recently, many reports are emerging about the role of the urinary microbiome in urothelial carcinogenesis, including gender disparity in bladder cancer and responses to treatments. The urinary microbiome may serve as a biomarker that can help with risk stratification as well as prediction of the response to intravesical therapies. However, the microbiome literature has been hampered by the lack of a unified standardized methodology for sample collection, type, preservation, processing, as well as bioinformatics analysis. Herein we describe and critique the literature on the association between urinary microbiome and bladder cancer and highlight some of the future directions.<\/jats:p>","DOI":"10.3390\/life13030812","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T04:10:48Z","timestamp":1679026248000},"page":"812","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Urinary Microbiome and Bladder Cancer"],"prefix":"10.3390","volume":"13","author":[{"given":"Nassib Abou","family":"Heidar","sequence":"first","affiliation":[{"name":"Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0738-8776","authenticated-orcid":false,"given":"Tariq A.","family":"Bhat","sequence":"additional","affiliation":[{"name":"Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usma","family":"Shabir","sequence":"additional","affiliation":[{"name":"Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Hussein","sequence":"additional","affiliation":[{"name":"Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA"},{"name":"Department of Urology, Cairo University, Giza 12613, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","unstructured":"(2022, December 05). Key Statistics for Bladder Cancer. Available online: https:\/\/www.cancer.org\/cancer\/bladder-cancer\/about\/key-statistics.html#:~:text=The%20American%20Cancer%20Society\u2019s%20estimates,men%20and%204%2C980%20in%20women)."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.eururo.2003.10.006","article-title":"Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and Progressive Tumours and Implications for Therapy","volume":"45","author":"Schrier","year":"2004","journal-title":"Eur. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eururo.2015.02.041","article-title":"\u201cSterile Urine\u201d and the Presence of Bacteria","volume":"68","author":"Wolfe","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.euf.2016.11.001","article-title":"The Urinary Tract Microbiome in Health and Disease","volume":"4","author":"Castillo","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/GCO.0000000000000298","article-title":"The urinary microbiota: A paradigm shift for bladder disorders?","volume":"28","author":"Brubaker","year":"2016","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/atm.2016.12.69","article-title":"The mycobiome of the human urinary tract: Potential roles for fungi in urology","volume":"5","author":"Ackerman","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e01283-01214","DOI":"10.1128\/mBio.01283-14","article-title":"The female urinary microbiome: A comparison of women with and without urgency urinary incontinence","volume":"5","author":"Pearce","year":"2014","journal-title":"mBio"},{"key":"ref_10","first-page":"14","article-title":"The human urine virome in association with urinary tract infections","volume":"6","author":"Ly","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41385-020-00372-5","article-title":"The microbiome and host mucosal interactions in urinary tract diseases","volume":"14","author":"Chonwerawong","year":"2021","journal-title":"Mucosal Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"14476","DOI":"10.1002\/jcb.28707","article-title":"The interplay between microbiota-dependent metabolite trimethylamine N-oxide, Transforming growth factor beta\/SMAD signaling and inflammasome activation in chronic kidney disease patients: A new mechanistic perspective","volume":"120","author":"Atef","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1479-5876-10-174","article-title":"Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury","volume":"10","author":"Fouts","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/GCO.0000000000000747","article-title":"The bladder microbiome and interstitial cystitis: Is there a connection?","volume":"33","author":"Abernethy","year":"2021","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.euo.2020.04.002","article-title":"Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naive Urothelial Bladder Cancer Patients","volume":"3","author":"Pederzoli","year":"2020","journal-title":"Eur. Urol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc703","article-title":"Helicobacter pylori and gastrointestinal tract adenocarcinomas","volume":"2","author":"Peek","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nrc2961","article-title":"Why do viruses cause cancer? Highlights of the first century of human tumour virology","volume":"10","author":"Moore","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1078-0432.CCR-13-1343","article-title":"Colonization of the human gut by E. coli and colorectal cancer risk","volume":"20","author":"Bonnet","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Oliva, M., Mulet-Margalef, N., Ochoa-De-Olza, M., Napoli, S., Mas, J., Laquente, B., Alemany, L., Duell, E.J., Nuciforo, P., and Moreno, V. (2021). Tumor-Associated Microbiome: Where Do We Stand?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031446"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ucl.2022.09.012","article-title":"The Association Between the Urinary Microbiome and Bladder Cancer","volume":"50","author":"Hussein","year":"2023","journal-title":"Urol. Clin. N. Am."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-3-0348-0837-8_8","article-title":"The role of inflammation in bladder cancer","volume":"816","author":"Gakis","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12967-022-03492-7","article-title":"Emerging role of human microbiome in cancer development and response to therapy: Special focus on intestinal microflora","volume":"20","author":"Sadrekarimi","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/apm.13097","article-title":"The discovery of bacterial biofilm in patients with muscle invasive bladder cancer","volume":"129","author":"Nadler","year":"2021","journal-title":"APMIS"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: Back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-9378-7-19","article-title":"Role of chronic E. coli infection in the process of bladder cancer- an experimental study","volume":"7","author":"Salman","year":"2012","journal-title":"Infect. Agents Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1096\/fj.201903266RR","article-title":"Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC","volume":"34","author":"Guo","year":"2020","journal-title":"FASEB J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.chom.2014.02.007","article-title":"Microbes, microbiota, and colon cancer","volume":"15","author":"Sears","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1128\/IAI.00188-08","article-title":"The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis","volume":"76","author":"Cosseau","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/apm.13011","article-title":"Bacillus Calmette-Guerin immunotherapy for bladder cancer: A review of immunological aspects, clinical effects and BCG infections","volume":"128","author":"Larsen","year":"2020","journal-title":"APMIS"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"370.e9","DOI":"10.1016\/j.urolonc.2020.12.011","article-title":"Investigating the association between the urinary microbiome and bladder cancer: An exploratory study","volume":"39","author":"Hussein","year":"2021","journal-title":"Urol. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/JU.0000000000001336","article-title":"The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage","volume":"205","author":"Oresta","year":"2021","journal-title":"J. Urol."},{"key":"ref_33","first-page":"359","article-title":"Urinary Microbiome Evaluation in Patients Presenting with Hematuria with a Focus on Exposure to Tobacco Smoke","volume":"11","author":"Moynihan","year":"2019","journal-title":"Res. Rep. Urol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1038\/s41598-018-29054-w","article-title":"The urinary microbiome associated with bladder cancer","volume":"8","author":"Situm","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1099\/jmm.0.001058","article-title":"Urinary microbiota\u2014A potential biomarker and therapeutic target for bladder cancer","volume":"68","author":"Bi","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1002\/cam4.2419","article-title":"Dysbiosis signatures of the microbial profile in tissue from bladder cancer","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcimb.2018.00167","article-title":"Profiling the Urinary Microbiota in Male Patients with Bladder Cancer in China","volume":"8","author":"Wu","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4824909","DOI":"10.1155\/2019\/4824909","article-title":"Common Core Bacterial Biomarkers of Bladder Cancer Based on Multiple Datasets","volume":"2019","author":"Mai","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.eururo.2021.05.018","article-title":"Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab?","volume":"80","author":"Pederzoli","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_40","first-page":"57","article-title":"Mini-review: Perspective of the microbiome in the pathogenesis of urothelial carcinoma","volume":"2","author":"Xu","year":"2014","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"555508","DOI":"10.3389\/fcimb.2020.555508","article-title":"Alterations in Urobiome in Patients With Bladder Cancer and Implications for Clinical Outcome: A Single-Institution Study","volume":"10","author":"Zeng","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1038\/s41598-020-67443-2","article-title":"Bladder cancer-related microbiota: Examining differences in urine and tissue samples","volume":"10","author":"Mansour","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/ajt.14038","article-title":"Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies","volume":"17","author":"Modena","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/1471-0528.15920","article-title":"The urobiome of continent adult women: A cross-sectional study","volume":"127","author":"Price","year":"2020","journal-title":"BJOG"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Hourigan, S.K., Zhu, W., Wong, W.S.W., Clemency, N.C., Provenzano, M., Vilboux, T., Niederhuber, J.E., Deeken, J., Chung, S., and McDaniel-Wiley, K. (2020). Studying the urine microbiome in superficial bladder cancer: Samples obtained by midstream voiding versus cystoscopy. BMC Urol., 20.","DOI":"10.1186\/s12894-020-0576-z"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ishaq, A., Zahid, S., Mukhtar, S., Azim, M.K., Akhtar, S., Irfan, M., and Malik, K.A. (2020). Comparative Analysis of Microbiome of Bladder Cancer Patients.","DOI":"10.21203\/rs.2.23701\/v1"},{"key":"ref_47","first-page":"615","article-title":"Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study","volume":"38","author":"Chipollini","year":"2020","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrurol.2014.361","article-title":"The microbiome of the urinary tract--a role beyond infection","volume":"12","author":"Whiteside","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"18321","DOI":"10.1073\/pnas.1406199111","article-title":"Microbiota organization is a distinct feature of proximal colorectal cancers","volume":"111","author":"Dejea","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/1097-0142(19920401)69:7<1776::AID-CNCR2820690721>3.0.CO;2-P","article-title":"Life style and occupational risk factors for bladder cancer in Germany. A case-control study","volume":"69","author":"Kunze","year":"1992","journal-title":"Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/sj.bjc.6604889","article-title":"Urinary tract infections and reduced risk of bladder cancer in Los Angeles","volume":"100","author":"Jiang","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00345-018-2257-z","article-title":"Role of urinary tract infection in bladder cancer: A systematic review and meta-analysis","volume":"36","author":"Bayne","year":"2018","journal-title":"World J. Urol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000058450","article-title":"Habitual intake of lactic acid bacteria and risk reduction of bladder cancer","volume":"68","author":"Ohashi","year":"2002","journal-title":"Urol. Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1111\/j.1365-2567.2008.02942.x","article-title":"A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer","volume":"128","author":"Matsumoto","year":"2009","journal-title":"Immunology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/ijc.31959","article-title":"Fermented dairy foods intake and risk of cancer","volume":"144","author":"Zhang","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.eururo.2004.09.011","article-title":"The probiotic approach: An alternative treatment option in urology","volume":"47","author":"Hoesl","year":"2005","journal-title":"Eur. Urol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000282409","article-title":"Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group","volume":"49","author":"Aso","year":"1992","journal-title":"Urol. Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/mi.2013.72","article-title":"From infection to immunotherapy: Host immune responses to bacteria at the bladder mucosa","volume":"6","author":"Ingersoll","year":"2013","journal-title":"Mucosal Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2014A current perspective","volume":"11","author":"Glickman","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e00511","DOI":"10.1128\/mSphere.00511-17","article-title":"Adaptation in a Fibronectin Binding Autolysin of Staphylococcus saprophyticus","volume":"2","author":"Mortimer","year":"2017","journal-title":"mSphere"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"45.e1","DOI":"10.1016\/j.urolonc.2013.06.005","article-title":"iNOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biology","volume":"32","author":"Shah","year":"2014","journal-title":"Urol. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/bju.14683","article-title":"Old instillations and new implications for bladder cancer: The urinary microbiome and intravesical BCG","volume":"124","author":"Bajic","year":"2019","journal-title":"BJU Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0022-5347(05)64362-5","article-title":"Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin)","volume":"168","author":"Seow","year":"2002","journal-title":"J. Urol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/1933719112466306","article-title":"Adhesion of Lactobacillus iners AB-1 to human fibronectin: A key mediator for persistence in the vagina?","volume":"20","author":"McMillan","year":"2013","journal-title":"Reprod. Sci."},{"key":"ref_66","unstructured":"(2023, January 12). Role of Microbiome in BCG Responsiveness Prediction (SILENTEMPIRE), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05204199."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.2019.37.7_suppl.423","article-title":"Association of the commensal urinary microbiome with response to Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy in nonmuscle invasive bladder cancer","volume":"37","author":"Sweis","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ajcn\/88.4.1083","article-title":"Cultured milk, yogurt, and dairy intake in relation to bladder cancer risk in a prospective study of Swedish women and men","volume":"88","author":"Larsson","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejogrb.2018.06.011","article-title":"Age, menopausal status and the bladder microbiome","volume":"228","author":"Curtiss","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.maturitas.2013.10.018","article-title":"Estrogenic action on innate defense mechanisms in the urinary tract","volume":"77","author":"Luthje","year":"2014","journal-title":"Maturitas"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fcimb.2013.00041","article-title":"The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults","volume":"3","author":"Lewis","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1462-5822.2006.00691.x","article-title":"Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli","volume":"8","author":"Eto","year":"2006","journal-title":"Cell. Microbiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","article-title":"Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: A randomized phase 1 trial","volume":"28","author":"Dizman","year":"2022","journal-title":"Nat. Med."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/3\/812\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:57:18Z","timestamp":1760122638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/3\/812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":73,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["life13030812"],"URL":"https:\/\/doi.org\/10.3390\/life13030812","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]}}}